Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease
- PMID: 21493561
- DOI: 10.1136/vr.d1217
Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease
Similar articles
-
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.J Vet Intern Med. 2016 Nov;30(6):1765-1779. doi: 10.1111/jvim.14586. Epub 2016 Sep 28. J Vet Intern Med. 2016. PMID: 27678080 Free PMC article. Clinical Trial.
-
Current use of pimobendan in canine patients with heart disease.Vet Clin North Am Small Anim Pract. 2010 Jul;40(4):571-80. doi: 10.1016/j.cvsm.2010.04.003. Vet Clin North Am Small Anim Pract. 2010. PMID: 20610012 Review.
-
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.J Vet Intern Med. 2018 Jan;32(1):72-85. doi: 10.1111/jvim.14885. Epub 2017 Dec 6. J Vet Intern Med. 2018. PMID: 29214723 Free PMC article. Clinical Trial.
-
Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.Vet Rec. 2003 Oct 4;153(14):439-40. Vet Rec. 2003. PMID: 14582738 No abstract available.
-
Pimobendan and its use in treating canine congestive heart failure.Compend Contin Educ Vet. 2011 Nov;33(11):E1. Compend Contin Educ Vet. 2011. PMID: 22101450 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources